MFRMs®
Oral neuroprotection for vision, hearing, and cognition
MFRMs are a patented class of orally active small molecules designed to reduce oxidative stress and metal imbalance across the eye, inner ear, and brain.
Overview
At a glance
Oral Molecules
Small molecules designed for systemic neuroprotective activity.
Dual Action
Combines radical scavenging with selective metal binding.
Dual Action
Combines radical scavenging with selective metal binding.
Preclinical Stage
Demonstrated efficacy across multiple neurodegenerative models.
Preclinical Stage
Demonstrated efficacy across multiple neurodegenerative models.
Broad Uses
Relevant to vision, hearing, cognition, aging, and trauma.
Broad Uses
Relevant to vision, hearing, cognition, aging, and trauma.
Science
How it works
MFRMs were designed to go beyond traditional antioxidants by combining free radical neutralization and metal-balancing activity in a single orally active molecule.
Neutralizes damaging free radicals
Selectively binds iron, copper, and zinc
Inhibits ferroptosis cell death
Helps restore redox balance in vulnerable tissues
Penetrates the eye, inner ear, and brain
Avoids key stability limits of many antioxidants
Benefits
What it protects
Vision
Supports retinal, lens, and corneal tissues against oxidative stress and degeneration.
Vision
Supports retinal, lens, and corneal tissues against oxidative stress and degeneration.
Hearing
Helps protect cochlear cells and neural function in noise and blast injury.
Hearing
Helps protect cochlear cells and neural function in noise and blast injury.
Brain
Targets oxidative and metal-linked pathways relevant to neurodegeneration and aging.
Brain
Targets oxidative and metal-linked pathways relevant to neurodegeneration and aging.
Status
A differentiated neuroprotective platform
MFRMs combine broad preclinical activity with a mechanism designed to address multiple drivers of degeneration.
Patented orally active small-molecule platform
Dual antioxidant and metal-binding mechanism
Demonstrated efficacy in vision protection models
Demonstrated efficacy in hearing protection models
Relevant to amyloid beta and neurodegenerative pathways
Potential use across healthy aging, veterinary, and military settings
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.
Want to learn more about our products?
Contact us to learn more about our ophthalmic and neuroprotective product portfolio.